James W Antoon1, Carlos G Grijalva2, Cary Thurm3, Troy Richardson3, Alicen B Spaulding4, Ronald J Teufel5, Mario A Reyes6, Samir S Shah7, Julianne E Burns8, Chén C Kenyon8, Adam L Hersh9, Derek J Williams1. 1. Division of Hospital Medicine, Monroe Carell Jr. Children's Hospital at Vanderbilt and Department of Pediatrics, Vanderbilt University School of Medicine, Nashville, Tennessee. 2. Department of Health Policy, Vanderbilt University Medical Center, Nashville, Tennessee. 3. Children's Hospital Association, Lenexa, Kansas. 4. Children's Minnesota Research Institute, Minneapolis, Minnesota. 5. Department of Pediatrics, Medical University of South Carolina, Charleston, South Carolina. 6. Department of Pediatrics, Division of Hospital Medicine, Nicklaus Children's Hospital, Miami, Florida. 7. Divisions of Hospital Medicine and Infectious Diseases, Cincinnati Children's Hospital Medical Center & Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio. 8. Center for Pediatric Clinical Effectiveness, Children's Hospital of Philadelphia and University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania. 9. Division of Infectious Diseases, Department of Pediatrics, University of Utah, Salt Lake City, Utah.
Abstract
BACKGROUND: Little is known about the clinical factors associated with COVID-19 disease severity in children and adolescents. METHODS: We conducted a retrospective cohort study across 45 US children's hospitals between April 2020 to September 2020 of pediatric patients discharged with a primary diagnosis of COVID-19. We assessed factors associated with hospitalization and factors associated with clinical severity (eg, admission to inpatient floor, admission to intensive care unit [ICU], admission to ICU with mechanical ventilation, shock, death) among those hospitalized. RESULTS: Among 19,976 COVID-19 encounters, 15,913 (79.7%) patients were discharged from the emergency department (ED) and 4063 (20.3%) were hospitalized. The clinical severity distribution among those hospitalized was moderate (3222, 79.3%), severe (431, 11.3%), and very severe (380, 9.4%). Factors associated with hospitalization vs discharge from the ED included private payor insurance (adjusted odds ratio [aOR],1.16; 95% CI, 1.1-1.3), obesity/type 2 diabetes mellitus (type 2 DM) (aOR, 10.4; 95% CI, 8.9-13.3), asthma (aOR, 1.4; 95% CI, 1.3-1.6), cardiovascular disease, (aOR, 5.0; 95% CI, 4.3- 5.8), immunocompromised condition (aOR, 5.9; 95% CI, 5.0-6.7), pulmonary disease (aOR, 5.3; 95% CI, 3.4-8.2), and neurologic disease (aOR, 3.2; 95% CI, 2.7-5.8). Among children and adolescents hospitalized with COVID-19, greater disease severity was associated with Black or other non-White race; age greater than 4 years; and obesity/type 2 DM, cardiovascular, neuromuscular, and pulmonary conditions. CONCLUSIONS: Among children and adolescents presenting to US children's hospital EDs with COVID-19, 20% were hospitalized; of these, 21% received care in the ICU. Older children and adolescents had a lower risk for hospitalization but more severe illness when hospitalized. There were differences in disease severity by race and ethnicity and the presence of selected comorbidities. These factors should be taken into consideration when prioritizing mitigation and vaccination strategies.
BACKGROUND: Little is known about the clinical factors associated with COVID-19 disease severity in children and adolescents. METHODS: We conducted a retrospective cohort study across 45 US children's hospitals between April 2020 to September 2020 of pediatric patients discharged with a primary diagnosis of COVID-19. We assessed factors associated with hospitalization and factors associated with clinical severity (eg, admission to inpatient floor, admission to intensive care unit [ICU], admission to ICU with mechanical ventilation, shock, death) among those hospitalized. RESULTS: Among 19,976 COVID-19 encounters, 15,913 (79.7%) patients were discharged from the emergency department (ED) and 4063 (20.3%) were hospitalized. The clinical severity distribution among those hospitalized was moderate (3222, 79.3%), severe (431, 11.3%), and very severe (380, 9.4%). Factors associated with hospitalization vs discharge from the ED included private payor insurance (adjusted odds ratio [aOR],1.16; 95% CI, 1.1-1.3), obesity/type 2 diabetes mellitus (type 2 DM) (aOR, 10.4; 95% CI, 8.9-13.3), asthma (aOR, 1.4; 95% CI, 1.3-1.6), cardiovascular disease, (aOR, 5.0; 95% CI, 4.3- 5.8), immunocompromised condition (aOR, 5.9; 95% CI, 5.0-6.7), pulmonary disease (aOR, 5.3; 95% CI, 3.4-8.2), and neurologic disease (aOR, 3.2; 95% CI, 2.7-5.8). Among children and adolescents hospitalized with COVID-19, greater disease severity was associated with Black or other non-White race; age greater than 4 years; and obesity/type 2 DM, cardiovascular, neuromuscular, and pulmonary conditions. CONCLUSIONS: Among children and adolescents presenting to US children's hospital EDs with COVID-19, 20% were hospitalized; of these, 21% received care in the ICU. Older children and adolescents had a lower risk for hospitalization but more severe illness when hospitalized. There were differences in disease severity by race and ethnicity and the presence of selected comorbidities. These factors should be taken into consideration when prioritizing mitigation and vaccination strategies.
Authors: Sameer S Kadri; Jake Gundrum; Sarah Warner; Zhun Cao; Ahmed Babiker; Michael Klompas; Ning Rosenthal Journal: JAMA Date: 2020-12-22 Impact factor: 56.272
Authors: James W Antoon; Derek J Williams; Cary Thurm; Michael Bendel-Stenzel; Alicen B Spaulding; Ronald J Teufel; Mario A Reyes; Samir S Shah; Chén C Kenyon; Adam L Hersh; Todd A Florin; Carlos G Grijalva Journal: J Hosp Med Date: 2021-05 Impact factor: 2.960
Authors: Roberta L DeBiasi; Xiaoyan Song; Meghan Delaney; Michael Bell; Karen Smith; Jay Pershad; Emily Ansusinha; Andrea Hahn; Rana Hamdy; Nada Harik; Benjamin Hanisch; Barbara Jantausch; Adeline Koay; Robin Steinhorn; Kurt Newman; David Wessel Journal: J Pediatr Date: 2020-05-13 Impact factor: 4.406
Authors: James W Antoon; Matt Hall; Alison Herndon; David P Johnson; Charlotte M Brown; Whitney L Browning; Todd A Florin; Leigh M Howard; Carlos G Grijalva; Derek J Williams Journal: J Pediatr Date: 2021-07-01 Impact factor: 4.406
Authors: Daniel F Gudbjartsson; Agnar Helgason; Hakon Jonsson; Olafur T Magnusson; Pall Melsted; Gudmundur L Norddahl; Jona Saemundsdottir; Asgeir Sigurdsson; Patrick Sulem; Arna B Agustsdottir; Berglind Eiriksdottir; Run Fridriksdottir; Elisabet E Gardarsdottir; Gudmundur Georgsson; Olafia S Gretarsdottir; Kjartan R Gudmundsson; Thora R Gunnarsdottir; Arnaldur Gylfason; Hilma Holm; Brynjar O Jensson; Aslaug Jonasdottir; Frosti Jonsson; Kamilla S Josefsdottir; Thordur Kristjansson; Droplaug N Magnusdottir; Louise le Roux; Gudrun Sigmundsdottir; Gardar Sveinbjornsson; Kristin E Sveinsdottir; Maney Sveinsdottir; Emil A Thorarensen; Bjarni Thorbjornsson; Arthur Löve; Gisli Masson; Ingileif Jonsdottir; Alma D Möller; Thorolfur Gudnason; Karl G Kristinsson; Unnur Thorsteinsdottir; Kari Stefansson Journal: N Engl J Med Date: 2020-04-14 Impact factor: 91.245
Authors: Rafi Kabarriti; N Patrik Brodin; Maxim I Maron; Chandan Guha; Shalom Kalnicki; Madhur K Garg; Andrew D Racine Journal: JAMA Netw Open Date: 2020-09-01
Authors: Julianne E Burns; Cary Thurm; James W Antoon; Carlos G Grijalva; Matt Hall; Adam L Hersh; Gabrielle Z Hester; Emilie Korn; Mario A Reyes; Samir S Shah; Balagangadhar R Totapally; Ronald J Teufel Journal: Pediatrics Date: 2022-09-01 Impact factor: 9.703
Authors: James W Antoon; James A Feinstein; Carlos G Grijalva; Yuwei Zhu; Emily Dickinson; Justine C Stassun; Jakobi A Johnson; Mert Sekmen; Yasas C Tanguturi; James C Gay; Derek J Williams Journal: Hosp Pediatr Date: 2022-05-01
Authors: Anna L Funk; Todd A Florin; Nathan Kuppermann; Daniel J Tancredi; Jianling Xie; Kelly Kim; Mark I Neuman; Lilliam Ambroggio; Amy C Plint; Santiago Mintegi; Terry P Klassen; Marina I Salvadori; Richard Malley; Daniel C Payne; Norma-Jean Simon; Adriana Yock-Corrales; Jasmine R Nebhrajani; Pradip P Chaudhari; Kristen A Breslin; Yaron Finkelstein; Carmen Campos; Kelly R Bergmann; Maala Bhatt; Fahd A Ahmad; Michael A Gardiner; Usha R Avva; Nipam P Shah; Laura F Sartori; Vikram J Sabhaney; Kerry Caperell; Nidhya Navanandan; Meredith L Borland; Claudia R Morris; Iker Gangoiti; Viviana Pavlicich; Nirupama Kannikeswaran; Maren M Lunoe; Pedro B Rino; April J Kam; Jonathan C Cherry; Alexander J Rogers; Shu-Ling Chong; Laura Palumbo; Carlos M Angelats; Andrea K Morrison; Maria Y Kwok; Sarah M Becker; Andrew C Dixon; Naveen Poonai; Michelle Eckerle; Muhammad Wassem; Stuart R Dalziel; Stephen B Freedman Journal: JAMA Netw Open Date: 2022-01-04
Authors: Valentine Wanga; Megan E Gerdes; Dallas S Shi; Rewa Choudhary; Theresa M Dulski; Sophia Hsu; Osatohamwen I Idubor; Bryant J Webber; Arthur M Wendel; Nickolas T Agathis; Kristi Anderson; Tricia Boyles; Sophia K Chiu; Eleanor S Click; Juliana Da Silva; Hannah Dupont; Mary Evans; Jeremy A W Gold; Julia Haston; Pamela Logan; Susan A Maloney; Marisol Martinez; Pavithra Natarajan; Kevin B Spicer; Mark Swancutt; Valerie A Stevens; Jessica Brown; Gyan Chandra; Megan Light; Frederick E Barr; Jessica Snowden; Larry K Kociolek; Matthew McHugh; David Wessel; Joelle N Simpson; Kathleen C Gorman; Kristen A Breslin; Roberta L DeBiasi; Aaron Thompson; Mark W Kline; Julie A Boom; Ila R Singh; Michael Dowlin; Mark Wietecha; Beth Schweitzer; Sapna Bamrah Morris; Emily H Koumans; Jean Y Ko; Anne A Kimball; David A Siegel Journal: MMWR Morb Mortal Wkly Rep Date: 2021-12-31 Impact factor: 35.301
Authors: Jeffrey I Campbell; Melanie M Dubois; Timothy J Savage; M Indriati Hood-Pishchany; Tanvi S Sharma; Carter R Petty; Gabriella S Lamb; Mari M Nakamura Journal: J Pediatr Date: 2022-02-28 Impact factor: 6.314